Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 6872149, 9 pages
http://dx.doi.org/10.1155/2016/6872149
Research Article

The Usefulness of Determining Neutrophil Gelatinase-Associated Lipocalin Concentration Excreted in the Urine in the Evaluation of Cyclosporine A Nephrotoxicity in Children with Nephrotic Syndrome

1Department of Pediatric Nephrology, Center for Pediatrics and Oncology, Chorzów, Poland
2Department of Urology, School of Medicine with Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland

Received 7 August 2016; Accepted 10 October 2016

Academic Editor: Vincent Sapin

Copyright © 2016 Ewa Gacka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Hyla-Klekot, Rola wybranych czynników ryzyka w rozwoju nefrotoksyczności leków immunosupresyjnych stosowanych w przeszczepie serca u dzieci i młodych dorosłych [Rozprawa habilitacyjna], Śląska Akademia Medyczna, Katowice, Poland, 2005.
  2. B. Chowbay, S. Cumaraswamy, and Y. Cheung, “Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients,” Pharmacogenetics, vol. 13, no. 2, pp. 89–95, 2003. View at Google Scholar
  3. D. Habashy, E. M. Hodson, and J. C. Craig, “Interventions for steroid-resistant nephrotic syndrome: a systematic review,” Pediatric Nephrology, vol. 18, no. 9, pp. 906–912, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Jarmużek, Ocena czynników klinicznych i genetycznych wpływających na rozwój niewydolności nerek u dzieci z zespołem nerczycowym. Rozprawa doktorska [Ph.D. thesis], Klinika Nefrologii, Transplantacji Nerek i Nadciśnienia Tętniczego (Instytut Pomnik-Centrum Zdrowia Dziecka w Warszawie), Warszawa, Poland, 2004.
  5. A. El-Husseini, “Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience,” Nephrology Dialysis Transplantation, vol. 20, no. 11, pp. 2433–2438, 2005. View at Publisher · View at Google Scholar
  6. V. Kon, M. Sugiura, T. Inagami, B. R. Harvie, I. Ichikawa, and R. L. Hoover, “Role of endothelin in cyclosporine-induced glomerular dysfunction,” Kidney International, vol. 37, no. 6, pp. 1487–1491, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Dziewanowski, B. Busz-Papież, M. Kurowski, and E. Kopeć, “Nefropatia pocyklosporynowa u chorych po przeszczepie serca—istotny problem kliniczny,” Kardiologia Polska, vol. 64, pp. 552–525, 2006. View at Google Scholar
  8. S. Schaub, M. Mayr, G. Hönger et al., “Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology,” Transplantation, vol. 84, no. 1, pp. 104–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Mishra, K. Mori, Q. Ma, C. Kelly, J. Barasch, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity,” American Journal of Nephrology, vol. 24, no. 3, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Devarajan, “Neutrophil gelatinase-associated lipocalin—an emerging troponin for kidney injury,” Nephrology Dialysis Transplantation, vol. 23, no. 12, pp. 3737–3743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Supavekin, W. Zhang, R. Kucherlapati, F. J. Kaskel, L. C. Moore, and P. Devarajan, “Differential gene expression following early renal ischemia/reperfusion,” Kidney International, vol. 63, no. 5, pp. 1714–1724, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Mishra, M. A. Qing, A. Prada et al., “Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534–2543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Cowland and N. Borregaard, “Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans,” Genomics, vol. 45, no. 1, pp. 17–23, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Cowland, O. E. Sørensen, M. Sehested, and N. Borregaard, “Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1β, but not by TNF-α,” Journal of Immunology, vol. 171, no. 12, pp. 6630–6639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. K. Meldrum, K. Hile, D. R. Meldrum, J. A. Crone, J. P. Gearhart, and A. L. Burnett, “Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-κB dependent mechanism,” The Journal of Urology, vol. 168, no. 1, pp. 248–252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Schmidt-Ott, K. Mori, A. Kalandadze et al., “Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia,” Current Opinion in Nephrology and Hypertension, vol. 15, no. 4, pp. 442–449, 2006. View at Publisher · View at Google Scholar
  17. A. Wasilewska, W. Zoch-Zwierz, K. Taranta-Janusz, and J. Michaluk-Skutnik, “Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity?” Pediatric Nephrology, vol. 25, no. 5, pp. 889–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Bennett, N. Piyaphanee, K. Czech, M. Mitsnefes, and P. Devarajan, “NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome,” Pediatric Nephrology, vol. 27, no. 5, pp. 807–812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Chen, F. Wang, and M.-H. Zhao, “Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis,” Rheumatology, vol. 48, no. 4, pp. 355–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Ding, Y. He, K. Li et al., “Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy,” Clinical Immunology, vol. 123, no. 2, pp. 227–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Nishida, H. Kawakatsu, Y. Okumura, and K. Hamaoka, “Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases,” Pediatrics International, vol. 52, no. 4, pp. 563–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Paragas, A. Qiu, Q. Zhang et al., “The Ngal reporter mouse detects the response of the kidney to injury in real time,” Nature Medicine, vol. 17, no. 2, pp. 216–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. P. Carlos, N. M. Sonehara, S. M. Oliani, and E. A. Burdmann, “Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model,” PLoS ONE, vol. 9, no. 7, Article ID e103660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sieber, D. Hoffmann, M. Adler et al., “Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity,” Toxicological Sciences, vol. 109, no. 2, pp. 336–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Moreno-Navarrete, M. Manco, J. Ibáñez et al., “Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance,” International Journal of Obesity, vol. 34, no. 2, pp. 240–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. G. Fassett, I. K. Robertson, M. J. Ball, D. P. Geraghty, J. W. Cardinal, and J. S. Coombes, “Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial,” Nephrology Dialysis Transplantation, vol. 27, no. 1, pp. 182–189, 2012. View at Publisher · View at Google Scholar · View at Scopus